CONCORD BIOTECH
Back to Cashflow Statement
|
CONCORD BIOTECH Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹11 Cr | ₹-14 Cr | ₹12 Cr | ₹2.83 Cr | ₹-4.48 Cr |
What is the latest Net Cash Inflow / Outflow ratio of CONCORD BIOTECH ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹11 Cr |
| Mar2025 | ₹-14 Cr |
| Mar2024 | ₹12 Cr |
| Mar2023 | ₹2.83 Cr |
| Mar2022 | ₹-4.48 Cr |
How is Net Cash Inflow / Outflow of CONCORD BIOTECH Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹11 Cr | Positive | |
| Mar2025 | ₹-14 Cr | Negative | |
| Mar2024 | ₹12 Cr | 311.12 | |
| Mar2023 | ₹2.83 Cr | Positive | |
| Mar2022 | ₹-4.48 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,224.6 Cr | 8.6% | -6.8% | -6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 8.6% |
-6.8% |
-6.5% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses